GoodRx
Corporate brand
UnclaimedAn American healthcare technology platform that compares prescription prices and provides medication discounts, telehealth, and related healthcare services.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
GoodRx is an American healthcare technology company focused on helping consumers find and afford prescription medicines. Its principal consumer product is a free website and mobile application that displays estimated prescription prices at pharmacies across the United States and generates coupons that can be presented at participating pharmacies. The service is intended primarily for people paying cash or seeking an alternative to the price available through insurance, although GoodRx has also developed products that work with insurers, pharmacy benefit managers, employers, and pharmaceutical manufacturers. The company was founded in Santa Monica in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Marlette. Its business model developed around the difficulty of comparing medication prices in a fragmented U.S. pharmacy market. Prices can differ substantially among pharmacies and payment channels, while consumers often lack a simple way to determine whether insurance or a discount arrangement offers the lower price. GoodRx aggregated this information into a consumer-facing search and coupon service, building relationships with pharmacy chains, pharmacy benefit managers, and drug manufacturers. GoodRx expanded beyond price comparison through GoodRx Gold, a paid membership program offering additional discounts, and GoodRx Care, a telemedicine service that allows users to consult licensed healthcare providers online for selected common conditions. The company acquired HeyDoctor in 2019, helping integrate virtual consultations and prescription access into its platform. It subsequently added health information, medication-adherence, manufacturer-solutions, and prescription-services capabilities. Its business-to-business activities include advertising and educational programs for pharmaceutical companies, tools for providers, and arrangements that can apply savings to eligible insured members. GoodRx became a public company in September 2020 through an initial public offering on Nasdaq under the symbol GDRX. Its growth accelerated during the late 2010s and early 2020s, although the company has faced competition from online pharmacies, insurers, pharmacy benefit managers, and other prescription-discount platforms. Its financial results have also reflected changing prescription transaction volumes, subscription trends, and the performance of its pharmaceutical manufacturer solutions business. The brand has attracted regulatory and public scrutiny over the handling of health-related user data. In 2020, reporting alleged that GoodRx had shared information associated with users' medication searches and pharmacy activity with advertising and technology companies. The Federal Trade Commission later announced a $1.5 million civil penalty in 2023, alleging violations involving health-information sharing and the agency's breach-notification rules. GoodRx said it had changed its practices and stopped sending prescription-related data to Facebook in 2020. GoodRx remains an active U.S. healthcare platform. Its current scope includes prescription price comparison, discount coupons, paid savings programs, telehealth, prescription fulfillment and services, consumer health content, provider tools, and programs developed with pharmaceutical manufacturers. The company is led by Wendy Barnes, who became president and chief executive officer in January 2025.
History
GoodRx was established in Santa Monica, California, in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Marlette. The founders sought to address the opacity and variability of prescription pricing in the United States, where the price paid for the same medicine can depend on the pharmacy, insurance arrangement, pharmacy benefit manager, manufacturer program, or cash-discount channel. GoodRx developed a website and mobile application that let consumers compare prices and obtain coupons for participating pharmacies. The company grew as a consumer-facing marketplace connecting patients with pharmacies and other healthcare participants. It also developed commercial relationships with pharmaceutical manufacturers and pharmacy benefit managers, creating a business-to-business component alongside its consumer discount products. GoodRx Gold added a subscription layer for users seeking additional discounts. The company reported strong net-income growth from 2017 through 2019, followed by a substantial 2020 loss associated in part with IPO-related expenses. GoodRx entered telehealth through its 2019 acquisition of HeyDoctor. The resulting GoodRx Care service enabled users to consult licensed providers online for selected conditions and, where clinically appropriate, obtain prescriptions. GoodRx later broadened its content and service portfolio through the acquisition of HealthiNation in 2021 and VitaCare Prescription Services in 2022. These transactions supported consumer health education, prescription workflows, and manufacturer-focused services. In September 2020, GoodRx completed its initial public offering on Nasdaq under the symbol GDRX. The company subsequently reported revenue growth in 2021, while also facing stronger competition and slower user growth in online pharmacy and healthcare services. Revenue declined modestly in 2023 but increased in 2024, when the company reported positive net income and improved adjusted EBITDA according to its public financial reporting. GoodRx's history also includes significant privacy scrutiny. Consumer Reports reported in 2020 that information connected with medication searches and pharmacy activity had been shared with technology and advertising companies. GoodRx announced changes to its practices and said it stopped sending prescription data to Facebook. In 2023, the FTC announced a settlement involving allegations that GoodRx had disclosed health information without sufficiently informed consent and had not complied with applicable breach-notification requirements. GoodRx agreed to the monetary penalty and related obligations without the matter establishing a general finding of wrongdoing beyond the settlement's terms. Leadership changed in 2023, when Bezdek and Hirsch stepped down as co-CEOs. Scott Wagner became interim CEO, while Bezdek became board chair and Hirsch assumed a chief mission officer role. Wendy Barnes became president and CEO on January 1, 2025. GoodRx continues to operate as an active U.S. digital-health and prescription-affordability company, combining consumer price comparison with telehealth, subscriptions, provider tools, health content, and pharmaceutical manufacturer solutions.
- 2025
Wendy Barnes becomes CEO
[4]Wendy Barnes assumes the president and CEO position on January 1, 2025.
- 2023
Co-CEO leadership structure ends
[1]Trevor Bezdek and Doug Hirsch leave the co-CEO roles; Scott Wagner becomes interim CEO.
- 2023
FTC privacy settlement
[3]The FTC announces a $1.5 million settlement concerning alleged disclosure of health information and breach-notification issues.
- 2022
Provider Mode launches
[1]GoodRx introduces Provider Mode, allowing healthcare professionals to compare medication costs and alternatives for patients.
- 2022
VitaCare acquisition
[1]GoodRx acquires VitaCare Prescription Services from TherapeuticsMD.
- 2021
HealthiNation acquisition
[1]GoodRx acquires HealthiNation, adding health video content and new pharmaceutical audience-engagement capabilities.
- 2020
Initial public offering
[2]GoodRx begins trading on Nasdaq under GDRX after pricing its IPO at $33 per share.
- 2019
HeyDoctor acquisition and GoodRx Care expansion
[1]GoodRx acquires HeyDoctor and incorporates virtual healthcare consultations into its service portfolio.
- 2017
Pharmaceutical partnerships expand
[1]GoodRx announces relationships with pharmaceutical companies intended to improve access to lower prescription costs.
- 2011
GoodRx is founded
[1]Trevor Bezdek, Doug Hirsch, and Scott Marlette establish GoodRx in Santa Monica, California.
Products and positioning
A consumer healthcare affordability and prescription-price transparency platform
Prescription affordability · 2011
GoodRx price comparison and coupons
GoodRx's core service lets users search for prescription medicines, compare estimated prices among participating U.S. pharmacies, and obtain discount coupons. Consumers can present coupons at pharmacies when the discounted cash price is preferable to their insurance price or when they lack coverage. The service is available through the GoodRx website and mobile application and is supported by a broad network of U.S. pharmacies.
Subscription savings
GoodRx Gold
GoodRx Gold is a paid membership program offering additional prescription discounts at participating pharmacies. It is designed for consumers who use medicines regularly or whose savings from the membership can exceed the subscription cost. GoodRx has expanded the program's pharmacy coverage through relationships with major chains and independent pharmacies.
Telemedicine · 2019
GoodRx Care
GoodRx Care provides online consultations with licensed healthcare providers for selected common conditions. Depending on the clinical assessment, a provider may issue a prescription that can be filled through a pharmacy. The service was strengthened by GoodRx's acquisition of HeyDoctor and is intended to provide an alternative access route for people who may face cost, convenience, or insurance barriers.
Clinical decision support · 2022
Provider Mode
Provider Mode is a tool for healthcare professionals that helps compare medication costs, payment methods, and possible drug alternatives while discussing treatment options with patients. It extends GoodRx's price-transparency model from consumers to prescribing and care-delivery settings.
Healthcare marketing and access services
Pharma Manufacturer Solutions
GoodRx's manufacturer-focused business provides pharmaceutical companies with ways to communicate with consumers, support medication access, and connect affordability programs with patients. The segment draws on GoodRx's consumer audience, prescription search activity, content capabilities, and prescription-services infrastructure.
Controversies
2024
Independent pharmacy litigation
Independent pharmacies filed class-action lawsuits naming GoodRx and major pharmacy benefit managers, alleging that arrangements involving generic-drug reimbursement suppressed payments and violated antitrust law. The allegations were disputed and the litigation's ultimate disposition is not established in the supplied reference material.
2023
Federal Trade Commission privacy enforcement
The FTC announced a $1.5 million settlement alleging that GoodRx disclosed users' personal health information to third parties for advertising without sufficiently informed consent and violated the FTC's health-breach notification requirements.
2020
Sharing of health-related user data
Consumer Reports reported that GoodRx shared information associated with medication searches, pharmacy activity, and advertising identifiers with Facebook, Google, and other technology companies. GoodRx announced changes to its practices and said it stopped sending prescription data to Facebook in March 2020.
Marketing campaigns
- 2017Pharmaceutical affordability partnerships
United States
GoodRx announced partnerships with pharmaceutical companies to help negotiate or present lower prescription costs and manufacturer-supported affordability options.
Outcome. Expanded GoodRx's role beyond pharmacy coupon distribution into manufacturer-supported access programs.
Brand decisions
2023
Restructure executive leadershipStrategyBackground
GoodRx changed its leadership structure after operating with co-chief executive officers.
Action taken
Trevor Bezdek and Doug Hirsch stepped down as co-CEOs, Scott Wagner became interim CEO, Bezdek became board chair, and Hirsch became chief mission officer.
Aftermath
The company later appointed Wendy Barnes as president and CEO effective January 1, 2025.
2022
Launch Provider ModeStrategyBackground
Consumers and clinicians often need to compare medication prices across insurance, cash, and alternative-drug options.
Action taken
GoodRx introduced a provider-facing mode for comparing costs and alternatives during patient care.
Aftermath
The product extended GoodRx's affordability proposition into the clinical workflow.
2020
Complete the initial public offeringOtherBackground
GoodRx pursued public-market financing after rapid growth in its consumer prescription-affordability business.
Action taken
GoodRx priced its Nasdaq IPO at $33 per share under the ticker GDRX.
Aftermath
The offering raised more than $1.1 billion and established GoodRx as a publicly traded company.
IPO price and gross proceeds. $33 per share; more than $1.1 billion raised (September 2020 IPO)
2019
Acquire HeyDoctorM&ABackground
GoodRx was primarily known for prescription price comparison and discounts but sought to add direct access to clinicians and prescriptions.
Action taken
The company acquired HeyDoctor and integrated its virtual-care capabilities into GoodRx Care.
Aftermath
GoodRx broadened from a price-transparency service into a combined affordability and telemedicine platform.
Recent events
- Unconfirmed
Reported
Amazon and GoodRx target US prescription subscribers as health insurance coverage slips[6]
Reuters reports that Amazon and GoodRx are targeting U.S. prescription subscribers as health insurance coverage slips.
- Unconfirmed
GoodRx acquires HealthiNation[7]
GoodRx said it has acquired HealthiNation, a video content provider. The financial terms were not announced.
Reported
GoodRx Help partners with charitable clinics[8]
GoodRx Help partnered with the National Association of Free and Charitable Clinics to subsidize nearly 1,000 medications at 23 clinics in 16 states.
Reported
GoodRx files initial IPO paperwork[9]
GoodRx reportedly filed initial paperwork with the SEC for a potential IPO. The article says the listing could take place later in 2020 or in early 2021.
- Unconfirmed
GoodRx acquires HeyDoctor[10]
GoodRx acquired HeyDoctor, an online medical services provider. The article does not state the financial terms or date of the acquisition.
- Unconfirmed
GoodRx launches online medical visits[10]
GoodRx launched a service through which Americans can get online medical visits with board-certified medical professionals and receive treatment, prescriptions, and lab tests for routine medical issues.
Reported
GoodRx announces acquisition of HeyDoctor[11]
GoodRx announced its acquisition of telemedicine startup HeyDoctor. The deal’s financial terms were not disclosed; the article says HeyDoctor would be rebranded as GoodRx Care.
Sources12 sources
- 1GoodRxen.wikipedia.org
- 2GoodRx Holdings, Inc. Form S-1 registration statementsec.gov
- 3FTC says GoodRx shared sensitive health information with third parties without consumer consentftc.gov
- 4GoodRx appoints Wendy Barnes as chief executive officerinvestors.goodrx.com
- 5GoodRx shared your sensitive health data with Facebookconsumerreports.org
- 6亚马逊与GoodRx在医保覆盖下滑之际瞄准美国处方药订阅用户news.google.com
- 7GoodRx收购HealthiNationsocaltech.com
- 8GoodRx Help与慈善诊所建立合作goodnewsnetwork.org
- 9GoodRx提交IPO初步文件medcitynews.com
- 10GoodRx 收购 HeyDoctorsocaltech.com
- 11GoodRx宣布收购HeyDoctorobserver.com
- 12GoodRx files to go public with a rare characteristic: Profitscnbc.com
Cite this profile: Cite the canonical profile. /brand-wiki/goodrx · Editorial policy · How profiles are compiled